Agenus announces Nature Medicine publication of Phase 2 UNICORN trial results

Agenus reported that results of the investigator-sponsored, multicenter Phase 2 UNICORN trial were published in the journal Nature Medicine. The study evaluated short-course preoperative (neoadjuvant) botensilimab (BOT) alone or combined with balstilimab (BAL).

Detected & updated continuously · Source: Nebula